Mary Wilson
Well-known member
1 June 2021
This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to adolescents (12- to 18-year-olds). As new evidence is continuously being generated and safety monitored on an ongoing basis, it is essential to consider the latest available information and recommendations issued by regulatory and public health authorities at national level.
The focus of this document is on the overall potential public health impact, rather than on the individual benefits and risks, of COVID-19 vaccination in adolescents.
https://www.ecdc.europa.eu/sites/de...s-for-COVID-19-vaccination-of-adolescents.pdf
This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to adolescents (12- to 18-year-olds). As new evidence is continuously being generated and safety monitored on an ongoing basis, it is essential to consider the latest available information and recommendations issued by regulatory and public health authorities at national level.
The focus of this document is on the overall potential public health impact, rather than on the individual benefits and risks, of COVID-19 vaccination in adolescents.
https://www.ecdc.europa.eu/sites/de...s-for-COVID-19-vaccination-of-adolescents.pdf